Analysis of the selective advantage conferred by a C-E1 fusion protein synthesized by rubella virus DI RNAs.
During serial passaging of rubella virus (RUB) in cell culture, the dominant species of defective-interfering RNA (DI) generated contains an in-frame deletion between the capsid protein (C) gene and E1 glycoprotein gene resulting in production of a C-E1 fusion protein that is necessary for the maintenance of the DI [Tzeng, W.P., Frey, T.K. (2006). C-E1 fusion protein synthesized by rubella virus DI RNAs maintained during serial passage. Virology 356 198-207.]. A BHK cell line stably expressing the RUB structural proteins was established which was used to package DIs into virus particles following transfection with in vitro transcripts from DI infectious cDNA constructs. Packaging of a DI encoding an in-frame C-GFP-E1 reporter fusion protein corresponding to the C-E1 fusion protein expressed in a native DI was only marginally more efficient than packaging of a DI encoding GFP, indicating that the C-E1 fusion protein did not function by enhancing packaging. However, infection with the DI encoding the C-GFP-E1 fusion protein (in the absence of wt RUB helper virus) resulted in formation of clusters of GFP-positive cells and the percentage of GFP-positive cells in the culture following infection remained relatively constant. In contrast, a DI encoding GFP did not form GFP-positive clusters and the percentage of GFP-positive cells declined by roughly half from 2 to 4 days post-infection. Cluster formation and sustaining the percentage of infected (GFP-positive) cells required the C part of the fusion protein, including the downstream but not the upstream of two arginine clusters (both of which are associated with RNA binding and association with mitochondrial p32 protein) and the E1 part through the transmembrane sequence, but not the C-terminal cytoplasmic tail. Among a collection of mutant DI constructs, cluster formation and sustaining infected cell percentage correlated with maintenance during serial passage with wt RUB. We hypothesize that cluster formation and sustaining infected cell percentage increase the likelihood of co-infection by a DI and wt RUB during serial passage thus enhancing maintenance of the DI. Cluster formation and sustaining infected cell percentage were found to be due to a combination of attenuated cytopathogenicity of DIs that express the C-E1 fusion protein and cell-to-cell movement of the DI. In infected cells, the C-GFP-E1 fusion protein was localized to potentially novel vesicular structures that appear to originate from ER-Golgi transport vacuoles. This species of DI expressing a C-E1 fusion protein that exhibits attenuated cytopathogenicity and the ability to increase the number of infected cells through cell-to-cell movement could be the basis for development of an attractive vaccine vector.
Claus
Claudia
C
Institute of Virology, University of Leipzig, Leipzig, Germany.
Tzeng
Wen-Pin
WP
Liebert
Uwe Gerd
UG
Frey
Teryl K
TK
D000818:Animals; D002460:Cell Line; D006224:Cricetinae; D003588:Cytopathogenic Effect, Viral; D003673:Defective Viruses / Q000235:genetics / Q000254:growth & development* / Q000472:pathogenicity; D050939:Gene Fusion / Q000235:genetics / Q000502:physiology*; D017930:Genes, Reporter; D049452:Green Fluorescent Proteins / Q000235:genetics / Q000378:metabolism; D050506:Mutant Chimeric Proteins / Q000032:analysis / Q000235:genetics / Q000502:physiology*; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D012412:Rubella virus / Q000254:growth & development* / Q000472:pathogenicity; D012692:Serial Passage; D022161:Transport Vesicles / Q000737:chemistry; D014758:Viral Core Proteins / Q000235:genetics / Q000502:physiology*; D014759:Viral Envelope Proteins / Q000235:genetics / Q000502:physiology*; D015678:Viral Structural Proteins / Q000032:analysis / Q000235:genetics / Q000502:physiology; D019065:Virus Assembly / Q000235:genetics / Q000502:physiology
D050506:Mutant Chimeric Proteins; D011993:Recombinant Fusion Proteins; D014758:Viral Core Proteins; D014759:Viral Envelope Proteins; D015678:Viral Structural Proteins; C074573:nucleocapsid protein (C), rubella virus; C061826:E1 envelope protein, Rubella virus; D049452:Green Fluorescent Proteins
J Virol. 2003 Sep;77(17):9502-10
12915564
Virology. 2005 Jul 5;337(2):327-34
15907967
Cell Biol Int. 2003;27(9):711-7
12972275
J Virol. 2004 Mar;78(5):2553-61
14963158
Arch Virol. 2004 Apr;149(4):779-89
15045564
Science. 1967 May 5;156(3775):659-61
6023662
J Virol. 1970 Apr;5(4):478-89
5465639
Intervirology. 1977;8(2):100-9
558175
J Clin Invest. 1986 May;77(5):1613-21
3009547
Virology. 1988 May;164(1):22-9
3363865
Virology. 1991 Jan;180(1):400-5
1984659
Virology. 1991 Dec;185(2):811-9
1962452
J Cell Biol. 1992 Aug;118(4):795-811
1500424
Virology. 1994 Aug 1;202(2):574-85
8030223
Adv Virus Res. 1994;44:69-160
7817880
Virology. 1995 Jan 10;206(1):216-26
7831776
Mol Biol Cell. 1995 Jan;6(1):7-20
7749196
Photochem Photobiol. 1995 Oct;62(4):651-6
7480149
J Virol. 1996 Apr;70(4):2184-90
8642641
J Submicrosc Cytol Pathol. 1996 Jan;28(1):101-8
8929632
J Virol. 1997 Jan;71(1):562-8
8985384
J Virol. 1997 Oct;71(10):7670-80
9311850
Virology. 1998 Jan 5;240(1):57-63
9448689
Mol Biol Cell. 1998 Jun;9(6):1265-78
9614173
Virology. 1998 Oct 25;250(2):359-70
9792846
Virology. 1999 Jun 20;259(1):74-84
10364491
J Virol. 1999 Sep;73(9):7805-11
10438871
J Gene Med. 2005 Jul;7(7):898-907
15759279
J Virol. 2005 Aug;79(16):10807-20
16051872
J Physiol. 2005 Oct 15;568(Pt 2):459-68
16037090
Arch Virol. 2006 Feb;151(2):327-46
16172842
Virology. 2006 Dec 5-20;356(1-2):198-207
16938325
Cell Microbiol. 2007 Apr;9(4):875-90
17087733
J Virol. 2000 Jun;74(12):5569-76
10823864
J Virol. 2000 Nov;74(22):10811-5
11044128
Cytometry. 2001 May 1;44(1):57-64
11309809
Virology. 2001 Oct 10;289(1):63-73
11601918
J Virol. 2003 Feb;77(3):1764-71
12525610
Biochem Biophys Res Commun. 2003 May 9;304(3):575-81
12729592
Mol Ther. 2003 Jul;8(1):13-20
12842424
Biochemistry. 2003 Aug 5;42(30):9185-94
12885253
Int J Mol Med. 2005 Jun;15(6):999-1003
15870906
Virology. 2003 Aug 1;312(2):261-9
12919732